Navigation Links
GenVec Announces Third Quarter 2009 Results Conference Call
Date:10/28/2009

GAITHERSBURG, Md., Oct. 28 /PRNewswire-FirstCall/ -- GenVec, Inc. (Nasdaq: GNVC) announced that it will release financial results for the third quarter ended September 30, 2009 on Thursday, November 5, 2009 after market close. GenVec will hold a conference call at 10:00 a.m. EST on Friday, November 6, 2009 to discuss the company's third quarter results.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081205/DC50112LOGO )

To listen to the live conference call, please dial 888-679-8040 (U.S. or Canada) or 617-213-4851 (international) and use access code 35178683. Participants may pre-register for the call anytime at:

https://www.theconferencingservice.com/prereg/key.process?key=PPCBK3H6R.

Pre-registrants will be issued a PIN number to use when dialing into the live call, which will provide quick access to the conference. An audio replay of the conference call will be available starting at 1:00 p.m. on November 6, 2009 through November 12, 2009. To listen to the audio replay, dial 888-286-8010 (U.S. or Canada) or 617-801-6888 (international) and use access code 28987203.

A live webcast of the conference call will be available on the Company's website and will be archived for 30 days. To access the webcast or the replay, go to www.genvec.com, click on "Investor Relations," and click on "Webcasts and Data."

About GenVec

GenVec, Inc. is a biopharmaceutical company developing novel therapeutic drugs and vaccines. GenVec's lead product, TNFerade(TM), is currently in a pivotal clinical study (PACT) in locally advanced pancreatic cancer. TNFerade has also bee
'/>"/>

SOURCE GenVec, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. GenVec Announces Registered Offering of $6 Million in Common Stock and Warrants
2. GenVec Receives an Approximately $2.5 Million Grant to Support Novel Cell Line Development
3. GenVec Reports Second Quarter 2009 Financial Results
4. GenVec Expands Contract Supporting Malaria Vaccine Program
5. GenVec Announces Registered Offering of $6 Million in Common Stock and Warrants
6. Medivation Announces Third Quarter 2009 Financial Results Teleconference and Webcast on November 4, 2009
7. TOPAZ Technologies Announces SoBran Inc. as New Customer
8. Oncolytics(R) Biotech Inc. Announces Issuance of 33rd U.S. Patent
9. LPBP Inc. announces final distribution
10. Pulmo BioTech Inc. Announces Cash Details of its Previously Announced Letter of Intent Intended to Bring its Pulmonary Vascular Diagnostic Product Candidate PulmoBind(TM) to the European Market
11. Myriant Technologies LLC Announces Appointment of Science Advisory Board Members
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... American Filtration and Separations Society will hold its 23rd Annual Technical ... Hotel in San Antonio, Texas. To further impact the separation society ... are proud to announce that the 2010 AFS Annual Technical Conference ... , ... Minneapolis, MN (PRWEB) December 16, 2009 -- ...
(Date:12/15/2009)... /PRNewswire-Asia-FirstCall/ -- China Sky One,Medical, Inc. ("China Sky ... ), a,leading fully integrated pharmaceutical company developing and ... ("PRC"), today,announced that the Company has 30 medicines ... the National Basic Medical Insurance, Industrial Injury Insurance,and ... The 30 medicines treat a variety of ...
(Date:12/15/2009)... Force Microscopy (AFM) have been developed and are opening up ... interface. The NeedleProbes’ cylindrical geometry enables researchers to measure ... - all in a single force distance curve. , ... ... constant diameter NeedleProbes are enabling unique measurements at ...
(Date:12/15/2009)... 15 On January 20th, 2010, the ... Medical Publication Professionals (ISMPP) will be held at ... More than 100 attendees are expected at this ... professionals, editors, publishers, medical writers and medical agencies ... and the impact of guidelines and regulations such ...
Breaking Biology Technology:American Filtration and Separations Society to Hold 23nd Annual Technical Conference 2American Filtration and Separations Society to Hold 23nd Annual Technical Conference 3American Filtration and Separations Society to Hold 23nd Annual Technical Conference 4China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory 2China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory 3New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM 2New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM 3Announcing ISMPP EU 2010 - the First European Meeting of the International Society for Medical Publication Professionals, Royal College of Physicians, London, UK, January 20, 2010 2
... proof-of-concept for diagnosing Parkinson,s ... Foundation awards grant to Molecular Biometrics for further ... development of Parkinson,s diagnostic, CHESTER, ... June issue of the peer-reviewed journal, Biomarkers in Medicine,demonstrated proof-of-concept ...
... BNVI ) today announced results for the second ... did not report any revenue for the three and ... $7,500 for the three and six,months ended June 30, ... with a Taiwanese company. In October of 2007,we terminated ...
... 5 NeoStem, Inc. (Amex: NBS ),announced today that ... Gables, a suburb of Miami, is targeted to open in,September. ... CelVida,LLC. With the opening of this center, NeoStem has secured ... a large U.S. market as well as a,growing sophisticated South ...
Other Biology Technology:Molecular Biometrics Announces Results of Parkinson's Disease Research and Receipt of Grant From Michael J. Fox Foundation to Advance Diagnostic Technology 2Molecular Biometrics Announces Results of Parkinson's Disease Research and Receipt of Grant From Michael J. Fox Foundation to Advance Diagnostic Technology 3Molecular Biometrics Announces Results of Parkinson's Disease Research and Receipt of Grant From Michael J. Fox Foundation to Advance Diagnostic Technology 4Molecular Biometrics Announces Results of Parkinson's Disease Research and Receipt of Grant From Michael J. Fox Foundation to Advance Diagnostic Technology 5Bionovo Reports Second Quarter 2008 Financial Results 2Bionovo Reports Second Quarter 2008 Financial Results 3Bionovo Reports Second Quarter 2008 Financial Results 4Bionovo Reports Second Quarter 2008 Financial Results 5Bionovo Reports Second Quarter 2008 Financial Results 6Bionovo Reports Second Quarter 2008 Financial Results 7NeoStem Forges Ahead in Its Plan to Open Adult Stem Cell Collection Centers in Key Locations that Can Serve as Hubs to Service Clients Nationwide 2NeoStem Forges Ahead in Its Plan to Open Adult Stem Cell Collection Centers in Key Locations that Can Serve as Hubs to Service Clients Nationwide 3
(Date:12/15/2009)... GenWay Clinical Laboratory, San Diego, California, has been ... Pathologists (CAP), based on results of a recent ... was advised of this national recognition and congratulated ... GenWay Biotech Inc. GenWay Clinical Laboratory is one ... CAP Laboratory Accreditation Program, begun in the early ...
(Date:12/15/2009)... 2006, a team of Spanish and American researchers found the ... Bonares, Huelva. Now they have published, for the first time, ... with the death of the young cetacean, possibly a baleen ... first discovery of the partial fossil remains of a whale ... Huelva Sands sedimentary formation, but it is the first time ...
(Date:12/15/2009)... a standard laboratory model organism, but there are ... analyze blood and blood-forming tissues in this species. ... easy-to-use laboratory resources from Cold Spring Harbor Laboratory ... features step-by-step protocols for the preparation, enumeration, ... and other hematopoietic tissues in the mouse. ...
Breaking Biology News(10 mins):Story of 4.5 million-year-old whale unveiled in Huelva 2Story of 4.5 million-year-old whale unveiled in Huelva 3New source of classical techniques for blood-based studies in the laboratory mouse 2Takeda to Establish Four Sales and Marketing Subsidiaries to Expand Its Operations in Mexico Turkey and Five Other Countries in Europe 5120 1Takeda to Establish Four Sales and Marketing Subsidiaries to Expand Its Operations in Mexico Turkey and Five Other Countries in Europe 5120 2Takeda to Establish Four Sales and Marketing Subsidiaries to Expand Its Operations in Mexico Turkey and Five Other Countries in Europe 5120 3Method to Identify Female Athletes at a High Risk for Knee Injury Discovered 58628 1Method to Identify Female Athletes at a High Risk for Knee Injury Discovered 58628 2Oakstone Medical Publishing Launches Unique Website Specifically Geared to Radiologists and Their Continuing Education Needs 58624 1Oakstone Medical Publishing Launches Unique Website Specifically Geared to Radiologists and Their Continuing Education Needs 58624 2
... randomized clinical trial for patients with previously untreated ... spread from the breast to other parts of ... bevacizumab (Avastin? in combination with standard chemotherapy had ... than patients who received the same chemotherapy without ...
... Institute for OneWorld Health, the first nonprofit pharmaceutical company ... Drug Designation from the two leading regulatory agencies in ... the European Agency for the Evaluation of Medicinal Products ... VL, also known as kala azar ("black fever"), is ...
... in the ecological community to agree a set of ... being led by the British Ecological Society's Journal of ... profile on river restoration. Opening the debate is a ... criteria for ecologically successful river restoration. Their aim is ...
Other Biology News:Bevacizumab Combined With Chemotherapy Improves Progression-Free Survival for Patients With Advanced Breast Cancer 2Bevacizumab Combined With Chemotherapy Improves Progression-Free Survival for Patients With Advanced Breast Cancer 3OneWorld Health drug receives 'Orphan' designation from U.S. and European regulatory agencies 2Putting ecology back into river restoration 2
... The S.c. EasyComp Transformation Kit ... transformation-competent Saccharomyces cerevisiae cells. Advantages over ... spheroplast formation or LiCl methods include:- Cells ... than 30 minutes - Competent cell preparation ...
Trop-2 Purified Anti-Human clone 162-46, Isotype Mouse IgG 1 , 100 µg Consult technical datasheet for details....
... of BAC (100+kb), fosmid (40kb), and large ... than any othe BAC vector. On command ... and easy recombinant DNA purification. Available with ... VC) vectors for the highest insert stability. ...
... (100+kb), fosmid (40kb), and large plasmid insert ... othe BAC vector. On command 20-50 fold ... recombinant DNA purification. Available with blue-white screening ... for the highest insert stability. Kits include ...
Biology Products: